$LDSN
Luduson G Inc.

2024 Q3 Form 10-Q Financial Statement

#000168316824007479 Filed on October 31, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit -$1.500M
YoY Change 611.82%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$9.665K
YoY Change 45.32%
Pretax Income -$1.510M
YoY Change 594.49%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.510M
YoY Change 594.49%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 563.5M shares
Diluted Shares Outstanding 563.5M shares

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $146.0K
Short-Term Investments
Other Short-Term Assets $12.50M
YoY Change 19400.78%
Inventory $0.00
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $12.76M
YoY Change 4205.14%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $806.2K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.500M
YoY Change
Total Long-Term Assets $9.306M
YoY Change 36.73%
TOTAL ASSETS
Total Short-Term Assets $12.76M
Total Long-Term Assets $9.306M
Total Assets $22.06M
YoY Change 210.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $292.0K
YoY Change 92.81%
LONG-TERM LIABILITIES
Long-Term Debt $987.4K
YoY Change -3.44%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $987.4K
YoY Change -3.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $292.0K
Total Long-Term Liabilities $987.4K
Total Liabilities $1.279M
YoY Change 8.97%
SHAREHOLDERS EQUITY
Retained Earnings -$1.911M
YoY Change -86.6%
Common Stock $56.35K
YoY Change 13.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.78M
YoY Change
Total Liabilities & Shareholders Equity $22.06M
YoY Change 210.63%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income -$1.510M
YoY Change 594.49%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-3184409
dei Entity Address Address Line1
EntityAddressAddressLine1
35/F, Central Plaza,
dei Entity Address Address Line2
EntityAddressAddressLine2
18 Harbour Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Wanchai
dei Entity Address Country
EntityAddressCountry
HK
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
0000
dei City Area Code
CityAreaCode
+852
dei Security12g Title
Security12gTitle
Common Stock, par value US$0.0001
dei Trading Symbol
TradingSymbol
LDSN
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
64102 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
12756262 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
285258 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6000000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6000000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
806158 usd
CY2023Q4 us-gaap Goodwill
Goodwill
806158 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2500000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
292015 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
257872 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
987438 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
987438 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
987438 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
987438 usd
CY2024Q3 us-gaap Liabilities
Liabilities
1279453 usd
CY2023Q4 us-gaap Liabilities
Liabilities
1245310 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
56347 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
50347 usd
dei Amendment Flag
AmendmentFlag
false
CY2023 LDSN Transfer To Treasury Stock15 August2023value
TransferToTreasuryStock15August2023value
usd
dei Document Type
DocumentType
10-Q
dei Local Phone Number
LocalPhoneNumber
2824 8560
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
563466410 shares
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
146006 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175002 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
46154 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
110256 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
177865 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
143722 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
503466410 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
503466410 shares
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
20138264 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1911144 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-14342505 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
5846106 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-214096 usd
CY2024Q3 us-gaap Interest Expense Other
InterestExpenseOther
9665 usd
us-gaap Interest Expense Other
InterestExpenseOther
53996 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6651 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-217422 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-220747 usd
us-gaap Net Income Loss
NetIncomeLoss
-220747 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
348210000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
348210000 shares
us-gaap Net Income Loss
NetIncomeLoss
12431361 usd
LDSN Stock Based Revenue
StockBasedRevenue
14000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
LDSN Proceeds From Sale Of Subsidiaries
ProceedsFromSaleOfSubsidiaries
0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-28996 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
220145 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
175002 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12056 usd
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001737193
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2024Q3 us-gaap Depreciation
Depreciation
0 usd
CY2023Q3 us-gaap Depreciation
Depreciation
0 usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55930
dei Entity Registrant Name
EntityRegistrantName
Luduson G Inc.
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
12500000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
0 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
0 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
9306158 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
6806158 usd
CY2024Q3 us-gaap Assets
Assets
22062420 usd
CY2023Q4 us-gaap Assets
Assets
7091416 usd
CY2024Q3 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
114150 usd
CY2023Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
114150 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
563466410 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
563466410 shares
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22637764 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
20782967 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22062420 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7091416 usd
CY2024Q3 us-gaap Revenues
Revenues
0 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
14000000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
-0 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
-0 usd
us-gaap Cost Of Revenue
CostOfRevenue
-0 usd
us-gaap Cost Of Revenue
CostOfRevenue
-0 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
0 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
14000000 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1500300 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
210771 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1512643 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
214096 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1500300 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-210771 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
12487357 usd
CY2024Q3 us-gaap Interest Income Other
InterestIncomeOther
0 usd
CY2023Q3 us-gaap Interest Income Other
InterestIncomeOther
6 usd
us-gaap Interest Income Other
InterestIncomeOther
0 usd
us-gaap Interest Income Other
InterestIncomeOther
6 usd
CY2023Q3 us-gaap Interest Expense Other
InterestExpenseOther
6657 usd
us-gaap Interest Expense Other
InterestExpenseOther
6657 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9665 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-55996 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6651 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1509965 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
12431361 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1509965 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-217422 usd
us-gaap Net Income Loss
NetIncomeLoss
12431361 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
563466410 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
563466410 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
348210000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
348210000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
544013855 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
544013855 shares
us-gaap Net Income Loss
NetIncomeLoss
-220747 usd
LDSN Stock Based Revenue
StockBasedRevenue
-0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1505500 usd
us-gaap Share Based Compensation
ShareBasedCompensation
205026 usd
us-gaap Increase Decrease In Inventories And Other Operating Assets
IncreaseDecreaseInInventoriesAndOtherOperatingAssets
-46154 usd
us-gaap Increase Decrease In Inventories And Other Operating Assets
IncreaseDecreaseInInventoriesAndOtherOperatingAssets
-0 usd
us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
46154 usd
us-gaap Increase Decrease In Accounts Receivable And Other Operating Assets
IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets
64102 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
34143 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4539 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28996 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-75284 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
3009 usd
LDSN Proceeds From Sale Of Subsidiaries
ProceedsFromSaleOfSubsidiaries
298438 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
295429 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
146006 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
232201 usd
us-gaap Interest Paid Net
InterestPaidNet
53996 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
LDSN Debt Converted To Common Stock
DebtConvertedToCommonStock
0 usd
LDSN Debt Converted To Common Stock
DebtConvertedToCommonStock
0 usd
LDSN Issuance Of Common Stock For Metaverse As Long Term Assets
IssuanceOfCommonStockForMetaverseAsLongTermAssets
2500000 usd
LDSN Issuance Of Common Stock For Metaverse As Long Term Assets
IssuanceOfCommonStockForMetaverseAsLongTermAssets
0 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-66123 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-303197 usd
CY2023 LDSN Shares Issued As Debt Conversion12 July2023value
SharesIssuedAsDebtConversion12July2023value
3482 usd
CY2023 LDSN Shares Issued As Debt Conversion13 July2023value
SharesIssuedAsDebtConversion13July2023value
1218 usd
CY2023 LDSN Shares Issued As Debt Conversion18 July2023value
SharesIssuedAsDebtConversion18July2023value
5026 usd
CY2023 LDSN Shares Issued As Debt Conversion31 July2023value
SharesIssuedAsDebtConversion31July2023value
2000 usd
CY2023 LDSN Shares Issued As Debt Conversion1 August2023value
SharesIssuedAsDebtConversion1August2023value
3500 usd
CY2023 LDSN Shares Issued At Price Stock Compensationvalue
SharesIssuedAtPriceStockCompensationvalue
200000 usd
CY2023 LDSN Treasury Stock Was Given For Purchase Of30 Movie Intelligent Properties21 September2023value
TreasuryStockWasGivenForPurchaseOf30MovieIntelligentProperties21September2023value
6000000 usd
CY2023 LDSN Shares Issued As Debt Conversion16 November2023value
SharesIssuedAsDebtConversion16November2023value
200 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
5846106 usd
us-gaap Net Income Loss
NetIncomeLoss
12431361 usd
LDSN Shares Issued For Purchase Of Metaverse Innovation Laboratory January102024
SharesIssuedForPurchaseOfMetaverseInnovationLaboratoryJanuary102024
2500000 usd
LDSN Shares Issued At Par To Mr.Lap Yan Cheung Companys Coo For Services Provided To Company April52024
SharesIssuedAtParToMr.LapYanCheungCompanysCooForServicesProvidedToCompanyApril52024
5500 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
20782967 usd
CY2024Q1 LDSN Shares Issued For Purchaseof Business10 January2024shares
SharesIssuedForPurchaseofBusiness10January2024shares
5000000 shares
CY2024Q1 LDSN Shares Issued For Purchase Of Metaverse Innovation Laboratory January102024
SharesIssuedForPurchaseOfMetaverseInnovationLaboratoryJanuary102024
2500000 usd
CY2024Q1 us-gaap Share Price
SharePrice
0.50
CY2024Q2 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zni0LlLvJqRi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> <span style="font-family: Wingdings">l</span> <span style="font-family: Times New Roman, Times, Serif">     <span id="xdx_86C_zIOUUeiVjXe3">Use of estimates and assumptions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing these condensed consolidated financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses during the periods reported. Actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
us-gaap Revenue Recognition Accounting Policy Gross And Net Revenue Disclosure
RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure
<p id="xdx_84B_eus-gaap--RevenueRecognitionAccountingPolicyGrossAndNetRevenueDisclosure_zce6AgP4RG12" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Wingdings">l</span> <span style="font-family: Times New Roman, Times, Serif">     <span id="xdx_867_zH1Y1m3Gwjwh">Revenue recognition</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company adopted Accounting Standards Codification (“ASC<i>”) 606 – Revenue from Contracts with Customers</i>” (“ASC 606”). Under ASC 606, a performance obligation is a promise within a contract to transfer a distinct good or service, or a series of distinct goods and services, to a customer. Revenue is recognized when performance obligations are satisfied and the customer obtains control of promised goods or services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for goods or services. Under the standard, a contract’s transaction price is allocated to each distinct performance obligation. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, the Company performs the following five steps:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 5%; text-align: justify"> </td> <td style="width: 3%; text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="width: 92%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the contract with a customer;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">identify the performance obligations in the contract;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">determine the transaction price;</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">allocate the transaction price to performance obligations in the contract; and</span></td></tr> <tr style="vertical-align: top"> <td style="text-align: justify"> </td> <td style="text-align: justify"><span style="font-family: Symbol; font-size: 10pt">·</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recognize revenue as the performance obligation is satisfied.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
0 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
563466410 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
503466410 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
503466410 shares
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2500000 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
2500000 shares
CY2024Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
2500000 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001683168-24-007479-index-headers.html Edgar Link pending
0001683168-24-007479-index.html Edgar Link pending
0001683168-24-007479.txt Edgar Link pending
0001683168-24-007479-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
image_001.jpg Edgar Link pending
ldsn-20240930.xsd Edgar Link pending
luduson_ex3101.htm Edgar Link pending
luduson_ex3102.htm Edgar Link pending
luduson_ex3201.htm Edgar Link pending
luduson_ex3202.htm Edgar Link pending
luduson_i10q-093024.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ldsn-20240930_def.xml Edgar Link unprocessable
ldsn-20240930_cal.xml Edgar Link unprocessable
ldsn-20240930_pre.xml Edgar Link unprocessable
ldsn-20240930_lab.xml Edgar Link unprocessable
luduson_i10q-093024_htm.xml Edgar Link completed